With the aim of improving the amount and delivery efficiency of genes taken by carbon nanotubes into human cancer cells, different generations of polyamidoamine dendrimer modified multi-walled carbon nanotubes (dMNTs) were fabricated, and characterized by high-resolution transmission electron microscopy, atomic force microscopy, x-ray photoelectron spectroscopy, Raman spectroscopy, Fourier transform infrared spectroscopy and thermogravimetric analysis, revealing the presence of dendrimer capped on the surface of carbon nanotubes. The dMNTs fully conjugated with FITC-labeled antisense c-myc oligonucleotides (asODN), those resultant asODN-dMNTs composites were incubated with human breast cancer cell line MCF-7 cells and MDA-MB-435 cells, and liver cancer cell line HepG2 cells, and confirmed to enter into tumor cells within 15 min by laser confocal microscopy. These composites inhibited the cell growth in time-and dose-dependent means, and down-regulated the expression of the c-myc gene and C-Myc protein. Compared with the composites of CNT-NH 2 -asODN and dendrimer-asODN, no. 5 generation of dendrimer-modified MNT-asODN composites exhibit maximal transfection efficiencies and inhibition effects on tumor cells. The intracellular gene transport and uptake via dMNTs should be generic for the mammalian cell lines. The dMNTs have potentials in applications such as gene or drug delivery for cancer therapy and molecular imaging.
Introduction
Antisense therapy is an important form of treatment for genetic disorders or tumors. Antisense oligodeoxynucleotides can bind the start location of mRNA translation inside cells, block translation of target mRNA into protein and finally inhibit target gene expression at protein levels [1] [2] [3] [4] [5] . To date, antisense therapy is still limited in application in clinical therapy because of two existing problems: rapid degradation by exo-and endo-nucleases and poor diffusion across the cell membrane [6] [7] [8] . Although some methods such as chemically modified oligonucleotides, oligonucleotides bound to virus or synthesized carriers, siRNA, microRNA, etc, have been explored to solve these problems [9] [10] [11] [12] , so far no optimal solution is found. Therefore, looking for more effective alternative delivery systems is of importance to solve the present problems.
Carbon nanotubes (CNTs), because of their unique mechanical, physical and chemical properties, have been actively investigated for their applications in various fields including molecular electronics, medical chemistry and biomedical engineering [13] [14] [15] . Carbon nanotubes can be functionalized to achieve improved biological properties and functions [16, 17] . Recently, some reports [18] [19] [20] [21] [22] show that carbon nanotubes can take various cargos such as small peptides, streptavidin and nucleic acids and penetrate mammalian cell membranes into the cytoplasm via sidewall functionalization. However, the amount of genes or peptides conjugated by each CNT is still limited. More important, these genes or peptides taken by CNTs have to be released out and then take effect in the cancer cells. As is known, a CNT is a foreign body to cells, the mechanism of the effects of CNTs on cells is not still well clarified [13, 22] , and therefore, the strategy of using less CNTs to take more genes or drugs into cells is an excellent choice to protect target cells.
Dendrimers are one class of novel special organic molecules: they can take different functional groups through a series of chemical modifications, and their interior cavities can serve as storage areas for a lot of genes or drugs because of the proton sponge effect [23] [24] [25] . Dendrimers are one kind of good nonviral gene delivery system because of their advantages of simplicity of use and ease of mass production compared to viral vectors with inherent risk [26, 27] . Our previous studies confirmed that the polyamidoamine (PAMAM) dendrimermodified magnetic nanoparticles can markedly enhance the efficiency of gene delivery systems [28] , dendrimer-modified single-walled carbon nanotubes can reduce the cytotoxicity of CNTs and enhance the cellular uptake of the CNTs [29] , CNTs can be filled with biomolecules such as DNA and peptides [30] [31] [32] and different generations of dendrimers can be grown on the surface of CNTs [33] . CNTs show potential toxicity to cells, animals and the environment [13, 22, 23] . However, to date, no report is closely associated with the use of dendrimer-modified CNTs as a gene delivery system.
Herein we selected antisense c-myc oligonucleotides as the research target, synthesized and characterized No. 1-5 generations of dendrimer-modified multi-walled carbon nanotubes (dMNTs) and investigated the dMNTs' penetrating efficiency and effects on breast cancer MCF-7 cells, MDA-MB-435 and liver cancer HepG2 cells with the aim of evaluating the transfection efficiency and therapeutic effects of dMNTs as a delivery system of FITC-labeled antisense c-myc oligonucleotides(asODN) for cancer therapy. Our results showed that dMNT-asODN composites can move across cellular membranes and enter into the cytoplasm within 15 min, inhibiting cell proliferation in dose-and time-dependent means, and down-regulating the expression of the c-myc gene and C-Myc protein. Compared with the composites of MNT-NH 2 -asODN and dendrimer-asODN, G 5.0 dendrimer-modified MNTs exhibit maximal transfection efficiency and inhibition effects on cancer cells. The dMNTs markedly enhance the inhibition effects of antisense c-myc on cancer cells. The intracellular gene transport and uptake via dendrimer-modified carbon nanotubes are generic for the mammalian cell lines. This gene delivery strategy may allow for more rational design of transfection reagents and applications in cancer therapy and molecular imaging in the near future.
Experimental details

Materials' source
Ethylenediamine, thionyl chloride (SOCl 2 ) and methylacrylate were purchased from Aldrich Chemical Company. Multiwalled carbon nanotubes with 99.9% purity were obtained from Shenzhen Nanoport Company (Shenzhen, China). Human breast cancer cell lines MCF-7 and MDA-MB-435, as well as liver cancer cell line HepG2, were obtained from the American Type Collection Company. DMEM (Gibco BRL, Gaithersburg, MD, USA) were supplemented with 10% fetal calf serum (FCS, Gibco BRL), penicillin (100 U ml −1 ), streptomycin (100 μg ml −1 ), L-glutamine 2 mM (ICN Biomedicals, Costa Mesa, CA, USA) and amphotericin B 2.5 μg ml −1 (Sigma-Aldrich). FITClabeled antisense c-myc oligonucleotides (asODNs) were purchased from Shanghai Sangon Biotechnology Company. The antisense c-myc sequence was complementary to the initiation five codons of human c-myc mRNA: 5 -AAC GTT GAG GGG CAT-3 ; and the control oligomer sequence (nsODN) is complementary to the sequence of the antisense oligomer: 5 -TTG CAA CTC CCC GTA-3 . One Step RNA PCR kit was purchased from TaKaRa Biotechnology Co. Ltd. The primers to amplify c-myc were designed according to the c-myc sequence; their sequences are as follows: upstream primer: 5 -CCGTATTTCTAGTCTTG-3 , downstream primer: 5 -GAGAAGGCGCTGGAGTCTTG-3 , yield length is 590 bp. GAPDH (internal control), forward primer 5 -CCA CCC ATG GCA AAT TCC ATG GCA-3 , reverse primer 5 -TCT AGA CGG GTC AGG TCC ACC-3 , yield length is 180 bp. Agarose was from Sigma (St Louis, USA). 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) was obtained from Dojin Laboratories (Kumamoto, Japan). Rabbit anti-human polyclonal antibody against C-Myc and horseradish peroxidase (HRP)-conjugated goat anti-rabbit secondary antibody were from Invitrogen Co., monoclonal anti-β-actin clone AC-15 (product no. A5441), anti-mouse IgG Cy3 conjugate secondary antibody (product no. C2181) and DAPI were purchased from Sigma Inc. Enhanced chemiluminescence kits were from Amersham Company (Germany).
Synthesis of dendrimer-functionalized multi-walled carbon nanotubes
Different generations of dendrimer-modified MNTs were prepared according to our previous report [34] . The steps are as follows: MNTs were added to 60% aqueous nitric acid. The mixture was placed in an ultrasonic bath for 60 min and then stirred for 24 h while being boiled under reflux. The mixture was then vacuum-filtered through a 0.22 μm Millipore polycarbonate membrane and subsequently washed with distilled water until the pH of the filtrate was approx. 7. The filtered solid was dried under vacuum for 24 h at 70
• C, yielding MWNT-COOH. The dried MWNT-COOH was suspended in SOCl 2 and stirred for 48 h at 70
• C. The solution was filtered, washed with anhydrous THF and dried under vacuum at room temperature for 48 h, generating MWNT-COCl. The dried MWNT-COCl was mixed with ethylenediamine at a ratio of 1:2 and stirred for 48 h at 80
• C. The resulting solid was separated by vacuum-filtration using a 0.22 μm Millipore polycarbonate membrane filter and subsequently washed with water, generating MWNT-NH 2 . 50 mg dried CNT-NH 2 was dispersed in 20 ml of 20% methylacrylate aqueous solution. The suspension was immersed in a sonicating water bath at 25
• C for 3 h. The particles were then washed with water. After washing, 20 ml of a 1:1 methanol-ethylenediamine solution was then added to the complex and the mixture was allowed to proceed under the same conditions. Stepwise growth using methylacrylate and ethylenediamine was repeated until No. 1-5 generations of dendrimer-modified MNTs were achieved. The dendrimermodified MWNTs (dMNTs) were then washed three times with 25 ml distilled water and were saved at 4
• C for further usage (see schematic S1 in supporting data available at stacks.iop.org/Nano/20/125101). The MNT-NH 2 and G 5.0 PAMMAM dendrimer were prepared according to previous reports [29, 34, 35] .
Characterization of dendrimer-modified multi-walled carbon nanotubes
High-resolution transmission electron microscopy (HR-TEM, Hitachi H-700H) was used to characterize dMNTs. Fourier transform infrared (FT-IR) spectroscopy of dMNTs was conducted with an FTS135 infrared spectrometer (BIO-RAD, USA) and zeta potential was measured with Zetasizer 2000 instruments (Malvern Co., UK). TGA measurement of dMNTs was performed by a TGA 2850 thermogravimetric analyzer (TA instruments) under N 2 in the temperature range 30-700
• C with an increasing rate of 5
• C min −1 . Atomic force microscopy (AFM) imaging of dMNTs was performed by tapping mode with standard Si/N tips and a Nanoscope III (Digital Instruments/Veeco Metrology Group, USA). Resonance Raman spectra of dMNTs were measured on a Raman infinity spectrophotometer (France) at a resolution of 4 cm −1 ; the 488 nm line with a power of 50 mW from an argon ion laser was used as the excitation source. Xray photoelectron spectroscopy (XPS) analysis of dMNTs was performed with an Axis Ultra spectrometer (Kratos, UK), using Mono Al KR (1486.71 eV) radiation at a power of 225 W (15 mA, 15 kV). To compensate for surface charge effects, binding energies were calibrated using the C 1s hydrocarbon peak at 284.8 eV.
Conjugation of asODNs with dMNTs, MNT-NH 2 and dendrimer
The pH of the solution was adjusted to 7.4. A suspension of 0.025 mg ml −1 dMNTs was mixed with 1 μM FITC-labeled antisense c-myc oligonucleotides for 2 h at room temperature, 0.025 mg ml −1 MNT-NH 2 was mixed with 1 μM asODNs for 2 h at room temperature and 1 μM asODN was mixed with 500 μl G 5.0 dendrimer for 2 h at room temperature. Then these mixtures were centrifuged for 10 min at 12 000 rpm and these precipitates including asODNs were collected and their volumes were adjusted to 1000 μl and they were kept in 4
• C for further usage.
Electrophoretic shift assay and zeta potential analysis
The suspensions of 0.2 μg of different generations of dendrimer-modified MNTs were respectively mixed with 5.0 nmol asODNs or control nsODNs (the free asODNs and nsODNs were used as controls) and were added into the sample wells in a 1% agarose gel in TAE buffer containing ethidium bromide. The gel was run for 1 h at 90 V and then photographed under UV light using a UVP gel documentation system (Upland, CA). Each sample was run in duplicate. The zeta potential of each sample was measured with Zetasizer 2000 instruments (Malvern Co., UK) [36] .
Cellular morphological observation by laser confocal microscope and HR-TEM
All the tumor cells were cultured at 37
• C in a humidified atmosphere of 5% CO 2 . The MCF-7 cells, MDA-MB435cells and HepG2 cells were seeded into 6-well plates with fibronection covered slides and cultured for 24 h, and then 100 μl of FITC-labeled asODN-dMNTs composites was added into the 6-well plates, then the slides were observed by a Zeiss LSM 510 laser confocal microscope. The remaining cells in the 6-well plates were collected and were embedded and made into TEM specimens, and then were observed via HR-TEM.
Immunofluorescent staining analysis
MDA-MB-435 cells with 20 μg ml −1 FITC-labeled asODNdMNTs were cultured on sterile coverslips at 37
• C in a humidified atmosphere of 5% CO 2 in air and cultured for 24 h. The cells were then washed briefly in PBS, fixed with −20
• C methanol for 10 min and with −20
• C acetone for 1 min. The coverslips were washed twice in PBS, and blocked with PBS containing 0.1% BSA for 10 min at room temperature followed by draining. The cell-side-up of the coverslips was incubated with monoclonal anti-β-actin clone AC-15 (1:2000) in PBS containing 1% BSA for 60 min and was washed for three times in PBS. The cell-side-up of the coverslips was incubated with anti-mouse IgG Cy3 conjugate antibody, at the recommended dilution, in PBS containing 1% BSA for 30 min and then was washed for three times in PBS. Then, the cellular nuclei were stained with DAPI for 1 h. One drop of aqueous mounting medium was added on the coverslip and inverted carefully on a glass slide. The cells were observed by a fluorescence microscope with appropriate filters and photographs taken [23] .
Cell viability and proliferation assays
MCF-7, MDA-MB-435 and HepG2 cells were cultured in DMEM medium supplemented with 10% FBS and 1% penicillin-streptomycin at 37
• C in a humidified atmosphere of 5% CO 2 for 48 h. These cells were collected and added into 24-well plates at the concentration of 5000 cells/well, and continued to culture for 24 h. Then the 100 μl dMNT-asODN complexes, 100 μl MNT-NH 2 -asODN and 100 μl G 5.0 dendrimer-asODN composites were added into the 24-well plates, not added into the control wells, and continued to culture for three days. MTT (5 mg ml −1 ) was prepared in PBS and 20 μl was added to each well, and the cells were incubated for 4 h at 37
• C. Then the medium was removed, 200 μl dimethyl sulfoxide was added to each well and the optical density (OD) was read at 515 nm. The cell viability was calculated by the following formula: cell viability (%) = OD (optical density) of the treated cells/OD of the non-treated cells. The cell numbers were counted by using the Trypan blue dye exclusion method and the percentage of cell growth was calculated as a ratio of the numbers of PAMAM-asODN treated cells and control cells with 0.5% DMSO vehicle [23, 27] .
Semiquantitative RT-PCR analysis
Cellular total RNAs were extracted by using the total RNA extraction kit (Promega Inc.,USA) according to the manufacturer's instructions. Single-strand cDNA was synthesized with oligo(dT) primer in a 20 μl reaction from 5 mg of total RNA using the SuperScript Preamplification System for First Strand cDNA synthesis system (Promega Company, USA) and diluted up to 80 μl. PCR was then performed with 1 μl of cDNA for 1 cycle at 94
• C for 2 min, followed by 1 cycle at 94
• C for 30 s, 60
• C for 30 s and 72
• C for 3 min repeated 30 times, using gene-specific primers and Taq polymerase. PCR products were analyzed by 1% agarose gel electrophoresis with ethidium bromide; GAPDH was used as the internal control to confirm equal amounts of the templates [27] .
Western blotting analysis
Cells were lysed in a protein lysis buffer (50 mM tris pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 5% 2-mercaptoethanol, 1% NP-40, 0.25% sodium deoxycholate, 5 mg ml −1 leupeptin, 5 mg ml −1 aprotinin, 10 mg ml −1 soybean trypsin inhibitor and 0.2 mM phenylmethyl sulfonylfluoride). Protein concentrations were determined using the Bradford method. Equal amounts of sample lysate were separated by sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and electrophoretically transferred onto polyvinylidene difluoride (PVDF) membranes (Millipore, Germany). The membrane was blocked with 0.1% BSA in a TBST buffer (20 mM tris, pH 7.4, 150 mM NaCl and 0.1% Tween-20) and incubated overnight at 4
• C with a rabbit antihuman, anti-c-Myc monoclonal antibody. Subsequently, the membrane was washed with a TBST buffer and incubated with a horseradish peroxidase-conjugated secondary antibody. The enhanced chemiluminescence kits (ECL) used were from the Amersham Company (UK). β-actin was used as a negative control [37] .
Statistical analysis
All data are presented in this paper as means result ± S.D. The significance of the results was statistically analyzed by a one-way analysis of variance (ANOVA) with Tukey's multiple comparison for pairwise comparison. Statistical significance was set at P < 0.05. All figures shown in this paper were obtained from three independent experiments with similar results. Figure 1 shows the results of different generations of dendrimer-modified MNTs characterized by HR-TEM, TGA and FT-IR. As shown in figure 1(a) , MNTs have a smooth surface and a diameter of 50 nm or so. As shown in figures 1(b) and (c), the grafted dendrimers can be clearly observed by HR-TEM and AFM. Also this can be further confirmed by TGA analysis, as shown in figure 1(e) . The grafted dendrimer content of the dMNTs can be calculated from TGA from the weight loss between 20 and 800
Results and discussion
Characterization of dMNTs
• C ( figure 1(d) ). The quantity of dendrimer grown on the MNTs increased as the generation of the dendrimer increased from 1.0 to 5.0. The weight losses at 800
• C on TGA plots show the average weight loss of 7.5%, 11.2%, 17.5%, 22.3% and 28.5% for dMNTs (generation 1-5), respectively. The dendrimer modification process was also proven by comparison of FT-IR spectra of the dMNTs and MNTs as shown in figure 1(e) . For amine-terminated MNTs (CNT-NH 2 ), at around 3500 cm −1 there is a strong characteristic band, at 1730 cm −1 no carboxyl stretching is detected, while at 1646, 1560 and 1462 cm −1 there are bands indicative of -CO-NH-stretching. After reaction with methylacrylate, G 0.5 dMNTs were formed, which is shown by the bands at 1656, 1543 and 1438 cm −1 , which are characteristic of -CO-NH-stretching. -COO-stretching for the ester groups was observed at 1732 cm MNTs, the FT-IR spectrum shows amide bands at 1647, 1550 and 1460 cm −1 . No ester stretching band at 1732 cm −1 is detected, indicating the formation of G 1.0 dendrimer-coated MNTs. Furthermore, a strong band at 3500 cm −1 indicates there are many amine groups on the surface of G 1.0 dMNTs. The dMNTs were also characterized by AFM, Raman spectra and XPS, as shown in figures S1-S4 in supporting data (available at stacks.iop.org/Nano/20/125101).
Electrophoretic shift assay and zeta potential analysis
Figure 2(a) shows the electrophoretic shift assay result of asODNs in the absence and presence of G 2.0 to G 5.0 -dMNTs, which showed that the amine-terminated dMNT composites could bind with asODNs and formed stable asODN-dMNT composites. As shown in figure 2(b) , dMNTs displayed positive charge properties: as the generation of dendrimers increased, the amount of positive charges displayed by dMNTs also increased accordingly, indicating the amount of NH 2 groups of dMNTs also increased accordingly; the amount of asODNs with negative charge absorbed by dMNTs also increased correspondingly. G 5.0 dMNTs absorbed the maximal amount of asODNs. Positively charged asODNdMNTs were very easily attached to negatively charged cell membranes to improve the endocytosis [27, 28] ; therefore the positively charged surface of asODN-dMNTs is key for cellular internalization.
Cell availability and proliferation assay
As shown in figure 3(A) , different generations of dMNTs can inhibit the growth of tumor cells with the inhibition rate of <9%: G 5.0 dMNTs exhibited lowest cellular toxicity to tumor cells. Whereas MNTs markedly inhibit the growth of tumor cells with an inhibition rate of 20% or so, therefore dendrimers can markedly improve the biocompatibility of MNTs, similar to the previous report [28] .
As shown in figure 3(B) , as the generation of dendrimers increased, the inhibition rate of asODN-dMNT composites gradually increased, and there existed a statistical difference among different generations of dMNTs (P < 0.05): G 5.0 dMNT-asODN composites have the maximum inhibition rate for tumor cells. Under identical conditions, as shown in figure 3(C) , the control MNT-NH 2 -asODN composites also exhibit inhibition effects on the tumor cells, but the inhibition rates were markedly lower than those caused by dMNTasODN composites, and there existed a statistical difference between dMNT-asODN composites and control groups such as asODN-MNT-NH 2 or dendrimer-asODN composites (P < 0.01), which highly suggest that dMNTs have advantages over MNTs, MNT-NH 2 and dendrimer in the asODN delivery.
As shown in figure 3(D) , G 5.0 dMNTs inhibited the growth of tumor cells in dose-dependent means. This is because the amount of asODN-dMNTs entering into cancer cells also increased as the amount of asODN-dMNTs in the medium increased. 
Semiquantitative RT-PCR and Western blot analysis
As shown in figures 4(A) and (B), as the generation of dendrimers increased, the expression levels of c-myc gene and C-Myc protein in tumor cells exhibited gradually downregulation (also see figure S6 in supporting data available at stacks.iop.org/Nano/20/125101). Compared with the control group, there existed a statistical difference between the asODN-dMNT group and asODN-dendrimer group, between the asODN-dMNT group and asODN-MNT-NH 2 group (P < 0.05), and asODN-G 5.0 dMNTs exhibited the strongest inhibition effects on the expression of c-myc gene and C-Myc protein among them.
Observation of entrance of asODN-dMNTs into cancer cells
As shown in figure 5(A) , FITC-labeled asODN-dMNTs displayed green fluorescence signals and dispersed very well in the medium under fluorescent microscopy. As shown in figures 5(B) and (C), FITC-asODN-dMNTs composites could enter into tumor cells within 15 min when they incubated with tumor cells. As the incubation time increased, the amount of FITC-labeled asODN-dMNTs in the cancer cells also increased accordingly and they mainly located in the cytoplasm; few could be observed in the cellular nucleus. HR-TEM pictures also confirmed that FITC-labeled asODN-dMNTs really located in the cytoplasm as shown in figures 5(D) and (E) (also see figure S5 in supporting data available at stacks.iop.org/Nano/20/125101). All these results fully demonstrate that asODN-dMNTs composites can enter into tumor cells highly efficiently and do not affect the inhibition function of asODNs on cancer cells. The dendrimerasODNs and MNT-NH 2 -asODNs also can enter into cancer cells within 1 h: however, their amounts in cancer cells were markedly lower than those of asODN-dMNTs under the identical incubation time (data not shown), which suggests that dMNTs may have maximum gene delivery efficiency among them.
Potential mechanism
As mentioned above, our results show that dMNTs can take antisense c-myc oligonucleotides into cancer cells highly efficiently and can release asODNs inside cancer cells. The released asODNs can bind the start location of c-myc mRNA translation in the cancer cells, block translation of c-myc mRNA into protein and inhibit expression of c-Myc proteins, finally inhibiting the growth of cancer cells. Therefore, the dMNTs should be a highly efficient gene delivery system for antisense therapy.
Regarding the mechanism of entrance of asODN-dMNTs composites into cancer cells, we consider dendrimer-modified MNTs exhibit positive charges, can absorb the asODNs with negative charge into their interior cavities and finally form a thin film wrapped on the surface of MNTs, as shown in figure 5(A) . As the generation of dendrimers increases, dMNTs absorb more asODNs and form closer thin films covering on the surface of MNTs, similar to Nam et al's reports [38] . The dendrimer on the surface of MNTs can form transient nanoscale holes in the membrane of cancer cells, similar to Banaszak Holl et al's reports [39] [40] [41] , markedly decreasing the integrity of the cell membranes. Then asODNdMNTs quickly enter into the cytoplasm, In the cellular microenvironment, under the action of different enzymes and ions, asODNs can be released out from the interior cavities of dendrimers and then bind the start sites of mRNA translation and inhibit protein synthesis. Because dMNTs can change the cellular microenvironment within a short time, and absorbed some ions, changing the pH of the environment, protecting asODNs from degradation caused by in vivo enzymes and prolonging the asODN' action time inside cancer cells, which finally markedly enhance the function of asODNs in cancer cells. Kostarelos et al [42] reported that cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. Conversely, our results show that cellular uptake of dendrimer-functionalized MNTs is highly dependent on the number of positive charges of functional groups and independent of cell types. The course of entrance of asODN-dMNTs composites into cancer cells may be an energy-independent nanoendocytotic pathway, similar to the nanosyringe model [43] .
Regarding the cellular toxicity of dMNTs, Banaszak Holl et al's reports showed that dendrimer is not toxic to cells up to 500 nM [39] [40] [41] . We consider that dMNTs' toxicity should be closely associated with the number of surface charges of dendrimers: molecules with negative charges such as asODNs, peptides and antibodies, can counteract the partial positive charges of dendrimers and can then reduce the cellular toxicity of dendrimers. However, the number of positive charges of dendrimers is also closely associated with gene delivery efficiency. Therefore, finding a balance between cellular toxicity and delivery efficiency is very important for developing the dMNTs-based gene delivery system.
Regarding the function of MNTs in the dMNT delivery system, MNTs own holes, which can be filled with genes or drugs. More importantly, MNTs own special physical, chemical and mechanical properties and can easily enter into the cytoplasm. A combination of dendrimer and MNTs can reduce the cytotoxicity of MNTs and simultaneously improve the delivery efficiency of dendrimer and MNTs. MNTs can absorb near-infrared light and release the heat energy to kill cancer cells or design the switch to control the release of drugs inside cancer cells [13] . In addition, MNTs can protect asODNs from degradation caused by in vivo enzymes and prolong the action time of asODNs in cancer cells, so MNTs can enhance the therapeutic effects of asODNs, and have intensive application prospects in cancer therapy in the near future.
Conclusions
PAMAM dendrimer-modified MNTs may be good gene transporters for mammalian cell lines and antisense therapy. As the generation of PAMAM dendrimer increases, the amount of asODNs absorbed by dMNTs also increased accordingly. The asODN-G 5.0 dMNTs exhibit the maximal delivery efficiency and inhibition effects on cancer cells among MNT-NH 2 -asODN composites, dendrimer-asODN composites and dMNT-asODN composites, which may be helpful to solve the current problem in antisense therapy. Further work will focus on clarifying distribution and the metabolism course of dMNTs in cancer cells. For asODNs, short peptides, antibodies and siRNA, the dMNTs should be general, high efficient delivery systems, and have great potential in applications such as gene or drug delivery for cancer therapy and molecular imaging in the near future.
